Pregnancy after cancer: For whom and when?

被引：6

作者：

Margulies, Anne Laure ^{[1
]}

Selleret, Lise ^{[2
,3
]}

Zilberman, Sonia ^{[2
,3
]}

Nagarra, Isabelle Thomassin ^{[4
]}

Chopier, Jocelyne ^{[4
]}

Gligorov, Joseph ^{[5
]}

Berveiller, Paul ^{[3
,6
]}

Ballester, Marcos ^{[2
,3
,7
]}

Darai, Emile ^{[2
,3
,7
]}

Chabbert-Buffet, Nathalie ^{[2
,3
,7
]}

机构：

[1] Hop Bichat Claude Bernard, AP HP, Dept Gynecol Obstet Med Reprod, F-75018 Paris, France

[2] Univ Paris 06, Hop Tenon, AP HP, Dept Gynecol Obstet Med Reprod, F-75020 Paris, France

[3] Reseau INCA Canc Associes La Grossesse CALG, F-75020 Paris, France

[4] Hop Tenon, Serv Radiol, F-75020 Paris, France

[5] Hop Tenon, Serv Oncol, F-75020 Paris, France

[6] Hop Trousseau, AP HP, Dept Obstet Gynecol, F-75012 Paris, France

[7] Univ Paris 06, UMRS 938, F-75005 Paris, France

来源：

BULLETIN DU CANCER | 2015年 / 102卷 / 05期

关键词：

Pregnancy; Cancer; Chemotherapy; Fertility; Onco-fertility; EARLY BREAST-CANCER; YOUNG-WOMEN; FERTILITY PRESERVATION; OVARIAN RESERVE; ADJUVANT CHEMOTHERAPY; REMAIN PREMENOPAUSAL; MUTATION CARRIERS; RISK; THERAPY; CRYOPRESERVATION;

D O I：

10.1016/j.bulcan.2015.03.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Planning a pregnancy for patients with a history of cancer, including breast cancer, is a clinical situation that becomes more and more common. Several specific items are to be discussed: decrease of fertility after cancer treatment, fertility preservation options, impact of pregnancy on cancer recurrence risk and appropriate interval between cancer and pregnancy. Programming pregnancy after cancer is doable in a multidisciplinary setting, and begins at cancer diagnosis to anticipate the various specific pitfalls. Favor adequate oncologic care remains the leading rule.

引用

页码：463 / 469

页数：7

共 55 条

[1] GnRH antagonists are safer than agonists: an update of a Cochrane review [J].

Al-Inany, Hesham G. ;

Youssef, Mohamed A. F. M. ;

Aboulghar, Mohamed ;

Broekmans, Frank ;

Sterrenburg, Monique ;

Smit, Janine ;

Abou-Setta, Ahmed M. .

HUMAN REPRODUCTION UPDATE, 2011, 17 (04) :435-435

[2] Pregnancies, breast-feeding, and breast cancer risk in the international BRCA1/2 carrier cohort study (IBCCS) [J].

Andrieu, Nadine ;

Goldgar, David E. ;

Easton, Douglas F. ;

Rookus, Matti ;

Brohet, Richard ;

Antoniou, Antonis C. ;

Peock, Susan ;

Evans, Gareth ;

Eccles, Diana ;

Douglas, Fiona ;

Nogues, Catherine ;

Gauthier-Villars, Marion ;

Chompret, Agnes ;

van Leeuwen, Flora E. ;

Kluijt, Irina ;

Benitez, Javier ;

Arver, Brita ;

Olah, Edith ;

Chang-Claude, Jenny .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (08) :535-544

[3]

[Anonymous], 2014, PLAN CANC 2014 2019

[4]

Averette HE, 1999, CANCER-AM CANCER SOC, V85, P2301, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2301::AID-CNCR1>3.0.CO

[5]

2-A

[6] Safety of fertility preservation by ovarian stimulation with letrozole and Gonadotropins in patients with breast cancer: A prospective controlled study [J].

Azim, Amr A. ;

Costantini-Ferrando, Maria ;

Oktay, Kutluk .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2630-2635

[7] The current fertility preservation consultation model: are we adequately informing cancer patients of their options? [J].

Balthazar, Ursula ;

Deal, Allison M. ;

Fritz, Marc A. ;

Kondapalli, Laxmi A. ;

Kim, Ja Yeon ;

Mersereau, Jennifer E. .

HUMAN REPRODUCTION, 2012, 27 (08) :2413-2419

[8] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].

Bines, J ;

Oleske, DM ;

Cobleigh, MA .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729

[9] How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to Cryopreservation of embrya, oocytes, or ovaries [J].

Blumenfeld, Zeev .

ONCOLOGIST, 2007, 12 (09) :1044-1054

[10]

Botelho F, 1998, AM J REPROD IMMUNOL, V39, P279

← 1 2 3 4 5 6 →